688238 Obio Technology
- 6.43
- -0.14-2.13%
Obio Technology News
Heyuan Biotech Investor Relations Activity Record List (October 24, 2024)
Heyuan Biotech: Announcement on asset impairment preparations for the first three quarters of 2024
Heyuan Biotech: Announcement on holding the results briefing for the third quarter of 2024
Announcement on holding the results briefing for the third quarter of 2024
Heyuan Biotech: Haitong Securities Co., Ltd.\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Haitong Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Heyuan Biotech Investor Relations Activity Record List (August 29, 2024)
Heyuan Biotech Investor Relations Activity Record Form (2024 Semi-Annual Results Briefing)
Announcement on holding the 2024 semi-annual results briefing
Resolutions of the Third Meeting of the Third Special Meeting of Independent Directors of the Board of Directors
Special report on the storage and actual use of funds raised in the 2024 semi-year
Announcement of Resolutions of the 11th Meeting of the Third Board of Supervisors
Verification opinions on the regulatory inquiry letter for the 2023 annual report of Heyuan Biotechnology (Shanghai) Co., Ltd. disclosed by Haitong Securities Co., Ltd.
Heyuan Biotech Investor Relations Activity Record Form (2023 and 2024 First Quarter Results Briefing)
Haitong Securities Co., Ltd.'s 2023 Continuous Supervision Annual Follow-up Report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Haitong Securities Co., Ltd. report on Heyuan Biotechnology (Shanghai) Co., Ltd.'s 2023 continuous supervision site inspection report
Tianjian Certified Public Accountants (Special General Partnership) Internal Control Audit Report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Tianjian Certified Public Accountants (Special General Partnership) Audit Report on the Annual Storage and Use of Funds Raised by Heyuan Biotechnology (Shanghai) Co., Ltd.
Special opinions of the board of directors on the independence of independent directors
“2023 Independent Director Debriefing Report” (Song Zhengqi)
Analysis
Price Target
No Data
No Data